Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1990-06-13
1992-05-26
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
5142255, 5142265, 5142315, 5142322, 5142332, 5142338, 5142355, 5142375, 514378, 514380, A61K 31535, A01N 4380
Patent
active
051168391
ABSTRACT:
A method of treating depression comprising administering to a patient an effective antidepressive amount of a compound of the formula (I) ##STR1## wherein the endocyclic dotted line ##STR2## is a single bond; the exocyclic dotted line ##STR3## is a double bond; A is oxygen; B is a group of the formula (II) ##STR4## wherein m is 0 and n is 0 or 1; R.sup.3, R.sup.4 and the nitrogen to which they are attached together represent an alicyclic amino having a total of 5 or 6 ring atoms, of which one ring atom is the nitrogen and one ring atom is optionally an additional heteroatom selected from the group consisting of nitrogen, oxygen and sulfur, the alicyclic amino being unsubstituted or, where there is an additional nitrogen heteroatom, the alicyclic amino having as a substituent a C.sub.1 -C.sub.3 alkyl on the additional nitrogen heteroatom; R.sup.1 is hydrogen or halogen; and R.sup.2 is an unsubstituted phenyl, a substituted phenyl having a substituent selected from the group consisting of C.sub.1-3 alkyl, C.sub.1-3 alkoxy, halogen and nitro, an unsubstituted 5- or 6-membered heterocyclic group having one or more of oxygen, sulfur or a nitrogen as heteroatoms, or a substituted 5- or 6-membered heterocyclic group having one or more of oxygen, sulfur or a nitrogen as heteroatoms and having at least one substituent selected from the group consisting of C.sub.1 -C.sub.3 alkyl, C.sub.1-3 alkoxy, halogen and nitro; or a pharmaceutically acceptable acid addition salt thereof.
REFERENCES:
patent: 4579860 (1986-04-01), Tomita et al.
Patent Abstracts of Japan, vol. 12, No. 467 (C-550)[3314], Dec. 7, 1988; JP-A-63-188625 (Mitsui Toatsu Chem. Inc.), Apr. 8, 1988.
Patent Abstracts of Japan, vol. 5, No. 89 (C-58)[761], Jun. 1981; JP-A-56 34 674 (Sankyo K.K), Jun. 4, 1981.
Patent Abstracts of Japan, vol. 6, No. 90 (C-104)[968], May 27, 1982; JP-A-57 21 377 (Shinogi Seiyaku K.K.), Apr. 2, 1982.
Iwata Nobuyoshi
Nagano Mitsuo
Yoshimi Kenji
Criares T. J.
Sankyo Company Limited
Waddell Frederick E.
LandOfFree
Use of isoxazolin-3-one derivatives as antidepressants does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of isoxazolin-3-one derivatives as antidepressants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of isoxazolin-3-one derivatives as antidepressants will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-419903